Literature DB >> 21883396

Intratumoral injection of OK-432 suppresses metastatic squamous cell carcinoma lesion inducing interferon-γ and tumour necrosis factor-α.

T Akeda, K Yamanaka, H Kitagawa, E Kawabata, K Tsuda, M Kakeda, Y Omoto, K Habe, K Isoda, I Kurokawa, H Mizutani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21883396     DOI： 10.1111/j.1365-2230.2011.04151.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  4 in total

1.  In vivo screening of S100B inhibitors for melanoma therapy.

Authors:  Danna B Zimmer; Rena G Lapidus; David J Weber
Journal:  Methods Mol Biol       Date:  2013

Review 2.  Toll-like receptor-4 modulation for cancer immunotherapy.

Authors:  Shanjana Awasthi
Journal:  Front Immunol       Date:  2014-07-25       Impact factor: 7.561

3.  Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Kaid Darwiche; Thomas Vogl; Eugene P Goldberg; Haidong Huang; Michael Simoff; Qiang Li; Robert Browning; Francis J Turner; Patrick Le Pivert; Dionysios Spyratos; Konstantinos Zarogoulidis; Seyhan I Celikoglu; Firuz Celikoglu; Johannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2013-07-18       Impact factor: 4.162

Review 4.  Activation of viral defense signaling in cancer.

Authors:  Maria Gonzalez-Cao; Niki Karachaliou; Mariacarmela Santarpia; Santiago Viteri; Andreas Meyerhans; Rafael Rosell
Journal:  Ther Adv Med Oncol       Date:  2018-08-29       Impact factor: 8.168
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.